rs17561681

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000810.4(GABRA5):​c.581-3857C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0395 in 152,182 control chromosomes in the GnomAD database, including 171 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.039 ( 171 hom., cov: 32)

Consequence

GABRA5
NM_000810.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.0840

Publications

4 publications found
Variant links:
Genes affected
GABRA5 (HGNC:4079): (gamma-aminobutyric acid type A receptor subunit alpha5) GABA is the major inhibitory neurotransmitter in the mammalian brain where it acts at GABA-A receptors, which are ligand-gated chloride channels. Chloride conductance of these channels can be modulated by agents such as benzodiazepines that bind to the GABA-A receptor. At least 16 distinct subunits of GABA-A receptors have been identified. Transcript variants utilizing three different alternative non-coding first exons have been described. [provided by RefSeq, Jul 2008]
GABRB3 (HGNC:4083): (gamma-aminobutyric acid type A receptor subunit beta3) This gene encodes a member of the ligand-gated ionic channel family. The encoded protein is one the subunits of a multi-subunit chloride channel that serves as the receptor for gamma-aminobutyric acid, a major inhibitory neurotransmitter of the mammalian nervous system. This gene is located on the long arm of chromosome 15 in a cluster with two other genes encoding related subunits of the family. This gene may be associated with the pathogenesis of several disorders including Angelman syndrome, Prader-Willi syndrome, nonsyndromic orofacial clefts, epilepsy and autism. Alternatively spliced transcript variants encoding distinct isoforms have been described. [provided by RefSeq, Jul 2013]
GABRB3 Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 43
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • epilepsy, childhood absence, susceptibility to, 5
    Inheritance: AD, Unknown Classification: DEFINITIVE, LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • childhood absence epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Lennox-Gastaut syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0556 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000810.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GABRA5
NM_000810.4
MANE Select
c.581-3857C>T
intron
N/ANP_000801.1
GABRA5
NM_001165037.2
c.581-3857C>T
intron
N/ANP_001158509.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GABRA5
ENST00000335625.10
TSL:1 MANE Select
c.581-3857C>T
intron
N/AENSP00000335592.5
GABRB3
ENST00000541819.6
TSL:1
c.200+5909G>A
intron
N/AENSP00000442408.2
GABRA5
ENST00000355395.9
TSL:5
c.581-3857C>T
intron
N/AENSP00000347557.5

Frequencies

GnomAD3 genomes
AF:
0.0395
AC:
6005
AN:
152062
Hom.:
171
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00927
Gnomad AMI
AF:
0.0264
Gnomad AMR
AF:
0.0270
Gnomad ASJ
AF:
0.112
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.0291
Gnomad FIN
AF:
0.0635
Gnomad MID
AF:
0.0728
Gnomad NFE
AF:
0.0571
Gnomad OTH
AF:
0.0378
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0395
AC:
6004
AN:
152182
Hom.:
171
Cov.:
32
AF XY:
0.0389
AC XY:
2895
AN XY:
74408
show subpopulations
African (AFR)
AF:
0.00925
AC:
384
AN:
41528
American (AMR)
AF:
0.0269
AC:
412
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.112
AC:
388
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.0289
AC:
139
AN:
4816
European-Finnish (FIN)
AF:
0.0635
AC:
672
AN:
10590
Middle Eastern (MID)
AF:
0.0748
AC:
22
AN:
294
European-Non Finnish (NFE)
AF:
0.0571
AC:
3884
AN:
67996
Other (OTH)
AF:
0.0374
AC:
79
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
293
586
878
1171
1464
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
78
156
234
312
390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0503
Hom.:
30
Bravo
AF:
0.0354
Asia WGS
AF:
0.0100
AC:
37
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
2.7
DANN
Benign
0.61
PhyloP100
0.084
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17561681; hg19: chr15-27178475; API